Susquehanna analyst James Friedman said it’s still early days for the CEO in his journey to renew Cognizant, but our sense is that his strategy is anchored by the intention to get back to basics. We believe there is nothing structural that limits CTSH from retracing industry growth. But this is a crawl, walk, run- process, and investors should be patient during the rebuild as the company readies for future success, says Susquehanna.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on CTSH:
- Sanders, Casar voice support for striking YouTube Music workers, AC says
- Cognizant price target raised to $53 from $45 at Barclays
- Cognizant price target raised to $67 from $54 at Deutsche Bank
- Cognizant price target lowered to $91 from $93 at Susquehanna
- Cognizant downgraded to Neutral on ‘uncertain outlook’ at Baird